# Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

> **NCT00082719** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 33 (actual)

## Conditions studied

- Bladder Cancer
- Urethral Cancer

## Interventions

- **BIOLOGICAL:** Recombinant Interferon Alfa

## Key facts

- **NCT ID:** NCT00082719
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00082719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00082719, "Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00082719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*